Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
VCd versus VRd in Newly Diagnosed Multiple Myeloma: Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG).
Kastritis E, Beksac M, Badelita SN, Katodritou E, Bila J, Spanoudakis E, Seval GC, Cvetkovic Z, Markovic O, Toprak SK, Dalampira D, Coriu D, Bezirgiannidou Z, Pirsic M, Valkovic T, Ursuleac I, Sretenovic A, Sevastoudi A, Batinic J, Barbu S, Roussou M, Gavriatopoulou M, Terpos E, Dimopoulos MA; Balkan Myeloma Study Group. Kastritis E, et al. Among authors: sretenovic a. Clin Lymphoma Myeloma Leuk. 2024 Aug 21:S2152-2650(24)00312-4. doi: 10.1016/j.clml.2024.08.007. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2024. PMID: 39304364
Validation of the second revision of the international staging system (R2-ISS) for overall survival in multiple myeloma in a real-world cohort: an analysis by the Balkan myeloma study group (BMSG).
Kastritis E, Katodritou E, Badelita S, Bila J, Seval GC, Cvetkovic Z, Coriu D, Spanoudakis E, Dalampira D, Sretenovic A, Sevastoudi A, Bojan A, Mitrovic M, Danaila C, Gavriatopoulou M, Roussou M, Charalampous C, Terpos E, Beksac M, Dimopoulos MA. Kastritis E, et al. Among authors: sretenovic a. Leuk Lymphoma. 2024 Dec;65(13):2064-2067. doi: 10.1080/10428194.2024.2391900. Epub 2024 Aug 14. Leuk Lymphoma. 2024. PMID: 39141607 No abstract available.
Prognostic effect of comorbidity indices in elderly patients with multiple myeloma.
Bila J, Jelicic J, Djurasinovic V, Vukovic V, Sretenovic A, Andjelic B, Antic D, Todorovic M, Mihaljevic B. Bila J, et al. Among authors: sretenovic a. Clin Lymphoma Myeloma Leuk. 2015 Jul;15(7):416-9. doi: 10.1016/j.clml.2015.03.004. Epub 2015 Mar 24. Clin Lymphoma Myeloma Leuk. 2015. PMID: 25873436
Prognostic Significance of Cereblon Expression in Patients With Multiple Myeloma.
Bila J, Sretenovic A, Jelicic J, Tosic N, Glumac I, Fekete MD, Antic D, Balint MT, Markovic O, Milojevic Z, Radojkovic M, Trajkovic G, Puric M, Pavlovic S, Mihaljevic B. Bila J, et al. Among authors: sretenovic a. Clin Lymphoma Myeloma Leuk. 2016 Nov;16(11):610-615. doi: 10.1016/j.clml.2016.08.007. Epub 2016 Aug 10. Clin Lymphoma Myeloma Leuk. 2016. PMID: 27618360
Is it possible to improve prognostic value of NCCN-IPI in patients with diffuse large B cell lymphoma? The prognostic significance of comorbidities.
Antic D, Jelicic J, Trajkovic G, Balint MT, Bila J, Markovic O, Petkovic I, Nikolic V, Andjelic B, Djurasinovic V, Sretenovic A, Smiljanic M, Vukovic V, Mihaljevic B. Antic D, et al. Among authors: sretenovic a. Ann Hematol. 2018 Feb;97(2):267-276. doi: 10.1007/s00277-017-3170-z. Epub 2017 Nov 12. Ann Hematol. 2018. PMID: 29130134
FCG (FLIPI, Charlson comorbidity index, and histological grade) score is superior to FLIPI in advanced follicular lymphoma.
Mihaljevic B, Jelicic J, Andjelic B, Antic D, Markovic O, Petkovic I, Jovanovic MP, Trajkovic G, Bila J, Djurasinovic V, Sretenovic A, Vukovic V, Smiljanic M, Balint MT. Mihaljevic B, et al. Among authors: sretenovic a. Int J Hematol. 2016 Dec;104(6):692-699. doi: 10.1007/s12185-016-2099-7. Epub 2016 Oct 6. Int J Hematol. 2016. PMID: 27714586
The possible benefit from total tumour resection in primary diffuse large B-cell lymphoma of central nervous system - a one-decade single-centre experience.
Jelicic J, Todorovic Balint M, Raicevic S, Ilic R, Stanisavljevic D, Bila J, Antic D, Balint B, Andjelic B, Djurasinovic V, Sretenovic A, Vukovic V, Mihaljevic B. Jelicic J, et al. Among authors: sretenovic a. Br J Neurosurg. 2016;30(1):80-5. doi: 10.3109/02688697.2015.1071328. Epub 2015 Sep 4. Br J Neurosurg. 2016. PMID: 26337736
Salvage Therapy With Polatuzumab Vedotin, Bendamustine, and Rituximab Prior to Allogeneic Hematopoietic Transplantation in Patients With Aggressive Lymphomas Relapsing After Therapy With Chimeric Antigen Receptor T-Cells-Report on Two Cases.
Gerhardt K, Jentzsch M, Georgi T, Sretenović A, Cross M, Bach E, Monecke A, Leiblein S, Hoffmann S, Todorović M, Bila J, Sabri O, Schwind S, Franke GN, Platzbecker U, Vučinić V. Gerhardt K, et al. Among authors: sretenovic a. Front Oncol. 2021 Sep 16;11:737645. doi: 10.3389/fonc.2021.737645. eCollection 2021. Front Oncol. 2021. PMID: 34604075 Free PMC article.
36 results